481 related articles for article (PubMed ID: 31766537)
1. Promises and Pitfalls of In Vivo Evolution to Improve Phage Therapy.
Bull JJ; Levin BR; Molineux IJ
Viruses; 2019 Nov; 11(12):. PubMed ID: 31766537
[TBL] [Abstract][Full Text] [Related]
2. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
[TBL] [Abstract][Full Text] [Related]
3. The Preclinical and Clinical Progress of Bacteriophages and Their Lytic Enzymes: The Parts are Easier than the Whole.
Abdelkader K; Gerstmans H; Saafan A; Dishisha T; Briers Y
Viruses; 2019 Jan; 11(2):. PubMed ID: 30678377
[TBL] [Abstract][Full Text] [Related]
4. Evolutionary Rationale for Phages as Complements of Antibiotics.
Torres-Barceló C; Hochberg ME
Trends Microbiol; 2016 Apr; 24(4):249-256. PubMed ID: 26786863
[TBL] [Abstract][Full Text] [Related]
5. Optimizing the Timing and Composition of Therapeutic Phage Cocktails: A Control-Theoretic Approach.
Li G; Leung CY; Wardi Y; Debarbieux L; Weitz JS
Bull Math Biol; 2020 Jun; 82(6):75. PubMed ID: 32533350
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.
Dąbrowska K; Abedon ST
Microbiol Mol Biol Rev; 2019 Nov; 83(4):. PubMed ID: 31666296
[TBL] [Abstract][Full Text] [Related]
7. Phage therapy for respiratory infections.
Chang RYK; Wallin M; Lin Y; Leung SSY; Wang H; Morales S; Chan HK
Adv Drug Deliv Rev; 2018 Aug; 133():76-86. PubMed ID: 30096336
[TBL] [Abstract][Full Text] [Related]
8. PhREEPred: Phage Resistance Emergence Prediction Web Tool to Foresee Encapsulated Bacterial Escape from Phage Cocktail Treatment.
Smug BJ; Majkowska-Skrobek G; Drulis-Kawa Z
J Mol Biol; 2022 Jul; 434(14):167670. PubMed ID: 35671831
[TBL] [Abstract][Full Text] [Related]
9. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
Viertel TM; Ritter K; Horz HP
J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
[TBL] [Abstract][Full Text] [Related]
10. A Multiwell-Plate Caenorhabditis elegans Assay for Assessing the Therapeutic Potential of Bacteriophages against Clinical Pathogens.
Manohar P; Loh B; Elangovan N; Loganathan A; Nachimuthu R; Leptihn S
Microbiol Spectr; 2022 Feb; 10(1):e0139321. PubMed ID: 35171008
[TBL] [Abstract][Full Text] [Related]
11. Computational models of populations of bacteria and lytic phage.
Krysiak-Baltyn K; Martin GJ; Stickland AD; Scales PJ; Gras SL
Crit Rev Microbiol; 2016 Nov; 42(6):942-68. PubMed ID: 26828960
[TBL] [Abstract][Full Text] [Related]
12. Virulence-associated factors as targets for phage infection.
de Melo AG; Morency C; Moineau S
Curr Opin Microbiol; 2024 Jun; 79():102471. PubMed ID: 38569419
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
Manohar P; Nachimuthu R; Lopes BS
BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
[TBL] [Abstract][Full Text] [Related]
14. Phage therapy administered noninvasively could be effective in thin tubes subject to episodic flow despite washout: a simulation study.
Blanco C; Chen IA
Phys Biol; 2019 Jul; 16(5):054001. PubMed ID: 31266001
[TBL] [Abstract][Full Text] [Related]
15. Profile of Paul E. Turner.
Viegas J
Proc Natl Acad Sci U S A; 2020 Aug; 117(32):18906-18908. PubMed ID: 32747551
[No Abstract] [Full Text] [Related]
16. Combatting intracellular pathogens using bacteriophage delivery.
Goswami A; Sharma PR; Agarwal R
Crit Rev Microbiol; 2021 Aug; 47(4):461-478. PubMed ID: 33818246
[TBL] [Abstract][Full Text] [Related]
17. Phage Therapy: Going Temperate?
Monteiro R; Pires DP; Costa AR; Azeredo J
Trends Microbiol; 2019 Apr; 27(4):368-378. PubMed ID: 30466900
[TBL] [Abstract][Full Text] [Related]
18. Interaction of phages, bacteria, and the human immune system: Evolutionary changes in phage therapy.
Jariah ROA; Hakim MS
Rev Med Virol; 2019 Sep; 29(5):e2055. PubMed ID: 31145517
[TBL] [Abstract][Full Text] [Related]
19. Phages and their potential to modulate the microbiome and immunity.
Federici S; Nobs SP; Elinav E
Cell Mol Immunol; 2021 Apr; 18(4):889-904. PubMed ID: 32901128
[TBL] [Abstract][Full Text] [Related]
20. Bacteriophage Adherence to Mucus Mediates Preventive Protection against Pathogenic Bacteria.
Almeida GMF; Laanto E; Ashrafi R; Sundberg LR
mBio; 2019 Nov; 10(6):. PubMed ID: 31744913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
